Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Fluoxetine in Autism (SOFIA)
This study has been completed.
Study NCT00515320   Information provided by Neuropharm
First Received: August 10, 2007   Last Updated: February 23, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autistic Disorder
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Child Development Disorders, Pervasive
Mental Disorders
Mental Disorders Diagnosed in Childhood
Pathologic Processes
Interventions listed in this trial
Fluoxetine
Placebo
Additional drug interventions recognized in this trial
Serotonin Uptake Inhibitors
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Therapeutic Uses
Sponsors listed in this trial
Neuropharm
Autism Speaks


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services